DERRILL PALIDWAR

In a powerful new article in The Irish Times, Andres Rodrigo highlights the importance of accelerating access to new medicines in Ireland. Explaining the importance of sustained funding and the benefit of targeted resource allocation, Andres outlines two key steps that can bridge the gap between innovation and patient care. Read the full article now here: https://bit.ly/4dKJxJy #PharmaLeadership #HealthcareInnovation #IrelandHealth #PatientCare

253

2 Comments

Don't miss our panel at #PatientsAsPartners Europe, "Value of Patient Involvement Along the Product Lifecycle," and check out our experience helping a pharma client overcome the challenges of the product launch phase of the lifecycle using a patient-centric product strategy here: https://lnkd.in/eZRhZk8a #pharma #patientengagement #PatientsEU2024

11

Cervical Disc Replacement Market Outlook on Key Growth Trends, Factors and Forecast 2033 https://lnkd.in/drFi6kmD The cervical disc replacement market is growing rapidly as advancements in spinal surgery, an increasing number of patients with degenerative disc diseases, and the rising demand for minimally invasive procedures drive the adoption of cervical disc replacement (CDR) technologies. Cervical disc replacement is a surgical procedure where a damaged or degenerated cervical disc is replaced with an artificial disc, aiming to maintain motion at the treated vertebral level. This procedure offers an alternative to spinal fusion, preserving the natural movement of the spine while providing pain relief and improved functionality for patients suffering from conditions like herniated discs, cervical spondylosis, and radiculopathy. The rising prevalence of cervical spine disorders, particularly among aging populations and individuals with physically demanding lifestyles, is a key driver of the cervical disc replacement market. As more people experience neck pain and other symptoms related to degenerative disc diseases, the demand for effective surgical treatments is increasing. Cervical disc replacement offers several advantages over traditional spinal fusion, including reduced recovery times, lower risk of adjacent segment degeneration, and better preservation of spinal mobility. These benefits are making CDR an increasingly popular choice among patients and healthcare providers, thereby boosting market growth. Technological advancements in cervical disc replacement devices are significantly contributing to the expansion of the market. Innovations in materials, such as the use of biocompatible metals and polymers, have improved the durability and functionality of artificial discs. Additionally, advances in surgical techniques, including the development of minimally invasive approaches, are making cervical disc replacement safer and more accessible to a broader range of patients. These technological improvements are enhancing patient outcomes, reducing complication rates, and increasing the adoption of cervical disc replacement procedures in spinal surgery. The competitive landscape of the cervical disc replacement market includes major medical device companies such as Medtronic, Zimmer Biomet, NuVasive, and Globus Medical. These companies are leading the market by developing and commercializing advanced cervical disc replacement devices, focusing on innovation, clinical research, and expanding their product portfolios. Strategic partnerships, mergers, and acquisitions are common as companies aim to strengthen their market positions and capitalize on the growing demand for CDR procedures. As the global population continues to age and the prevalence of cervical spine disorders increases, the cervical disc replacement market is poised for sustained growth, driven by ongoing technological advancemen

1

We are just 3 days away from Ireland's flagship #MedtechRising Conference and Annual Medtech Awards, taking place on the 05 December in Galway, jointly hosted by Irish Medtech, Enterprise Ireland, and IDA Ireland for the past 17 years. 34+ Speakers across 9 sessions, this unmissable gathering of 500 medtech industry leaders in Galway. Reserve your conference place today at - www.medtechrising.ie Moderated by Anton Savage, Broadcaster & Journalist, Session 7 will focus on 'Unleashing Productivity: The Impact of Digitalisation and AI in Manufacturing'. Despite all the clear benefits that digital and AI can deliver, most #manufacturers are not realising the full potential of this opportunity. A global survey of almost 1,800 manufacturing executives across seven industries found that 89% of companies plan to implement AI in their production networks and 68% have already started implementing AI solutions. Yet only 16% of companies have achieved their AI-related targets. David Gibson, Commercial Manager, Digital Manufacturing Ireland, Kieran Noonan, Site Director of Operations and Global Enterprise Excellence, Abbott and Margaret Stokes, Manufacturing Associate Director, Zimmer Biomet will explore what #medtech companies can achieve by incorporating #digital tools and #AI, to ensure that #leanmanufacturing principles remain effective in an increasingly #digital world. Adrienne McDonnell

40

🚨 New MHRA Policy Alert! 🚨 On May 21, 2024, the MHRA announced a groundbreaking policy for the UK market, recognizing international regulatory approvals for medical devices. 🌍 This move aims to streamline the approval process, reduce regulatory burdens, and focus on high-risk and innovative products. Key Points: ➡️ Recognition of approvals from Australia, Canada, EU, and USA. ➡️ Reduced duplication for manufacturers. ➡️ Focus on high-risk and novel devices. Read the full NAMSA details here: https://lnkd.in/ggiQ-_4p #MedicalDevices #NAMSAKnows #RegulatoryAffairs #MHRA #HealthcareInnovation

13

🚨 New MHRA Policy Alert! 🚨 On May 21, 2024, the MHRA announced a groundbreaking policy for the UK market, recognizing international regulatory approvals for medical devices. 🌍 This move aims to streamline the approval process, reduce regulatory burdens, and focus on high-risk and innovative products. Key Points: ➡️ Recognition of approvals from Australia, Canada, EU, and USA. ➡️ Reduced duplication for manufacturers. ➡️ Focus on high-risk and novel devices. Read the full NAMSA details here: https://lnkd.in/ggiQ-_4p #MedicalDevices #NAMSAKnows #RegulatoryAffairs #MHRA #HealthcareInnovation

7

We are also very excited for euroPLX 85 Dublin and also to welcoming PharmaPath in Dublin. Thank you for your registration. See you very soon Evgenia Vasilopoulou and Valeria Leventaki 🇮🇪. #europlx #raucon #businessdevelopment #business #development #event #sales #events #tips #tip #partnering #success #pro #networking #network #pharma #pharmaceutical #opportunities #businessopportunities #networkingevent #benchmark

2

When it comes to recruiting for molecular diagnostics, Cerca Talent doesn’t just fill roles—we shape futures. With deep industry knowledge and a tailored approach, we help companies stay ahead of the curve. Leading the Way in Diagnostics Recruitment Ready to grow your team with the right talent? #LifeSciencesRecruitment #DiagnosticsHiring #TalentAcquisition #Leadership

10

🔍 Delve into the future of MedTech with this compelling report from IDA Ireland! Discover how the industry is evolving and the pivotal role of digital transformation, innovation, and fostering a strong ecosystem for continued success. What strategies do you believe are crucial for MedTech companies to excel in the years ahead? #MedTech #Innovation #DigitalTransformation #DigitalHealth https://lnkd.in/ejyQsSQU

6

*European Pharma Takes on Antibiotic Resistance: A Bold Incentive Proposal* Antimicrobial resistance (AMR) is a global health crisis, and the European pharmaceutical industry is stepping up with an innovative solution: the Transferable Exclusivity Extension (TEE) voucher system. Modeled after the U.S. Priority Review Voucher (PRV), the TEE aims to incentivize the development of groundbreaking antibiotics by offering financial and market-driven rewards. With pilot programs under consideration, this initiative could redefine antibiotic innovation. 📖 Read more about this transformative approach and its potential to balance financial incentives with public health needs. Let’s discuss how incentives like TEE can drive innovation in critical areas like antibiotics R&D. #Antibiotics #PharmaInnovation #AMR #R&D#PRV#FDA #EMA #Priorityreviewvoucher#CleracsConsulting#KYBORA#ThePRVFundProject

3

If you're after better results in your wound care practice, take a look at the results VENDAJE® is achieving. Click here to read the published paper: https://lnkd.in/eKB72wXx #BSEM #VENDAJE #BioStem #woundcare

13

1 Comment

BioStem Technologies (OTC: BSEM) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers @BSEM_Tech https://lnkd.in/g-xNS7Qr #stockstowatch #stocksinnews #investors #daytrader #PrismMarketView #PrismMediaWire #PrismDigitalMedia

4

CHG Compatibility Testing: Your Gateway to Safer, More Effective Healthcare Products At Eurofins CRL, we understand the critical role Chlorhexidine Gluconate (CHG) plays in infection prevention. That's why we're committed to providing top-tier CHG Compatibility Testing for medical devices and healthcare products. Ensure your innovations work harmoniously with this vital antiseptic agent. The CHG Challenge in Healthcare: Chlorhexidine Gluconate is a cornerstone in infection control, but its effectiveness can be compromised by incompatible materials. Our testing helps you: • Maintain CHG's powerful antimicrobial properties • Prevent potential adverse patient reactions • Ensure your product's integrity in CHG-rich environments Our Comprehensive CHG Compatibility Testing Approach: 1. Initial Consultation: We work with you to understand your product and its intended use. 2. Custom Protocol Development: Our experts design a testing protocol tailored to your specific needs. 3. Rigorous Testing: We simulate real-world conditions to assess CHG compatibility. 4. Detailed Analysis: Our scientists evaluate both immediate and long-term interactions with CHG. 5. Clear Reporting: Receive comprehensive results with actionable insights for your development team. Who Benefits from Our CHG Compatibility Testing? • Wound care solution developers • Surgical prep product manufacturers • Personal care companies entering healthcare markets Don't let CHG compatibility questions slow down your innovation. Partner with Eurofins CRL to ensure your healthcare products are safe, effective, and market-ready. Ready to take the next step in your product development journey? Contact us today to discuss how our CHG Compatibility Testing can support your goals and accelerate your path to market. https://lnkd.in/d2FpGjk3 #PersonalCare #Eurofins #EfficacyTesting #HandwashTesting #HandSanitizerTesting

5

Discover how our cutting-edge eClinical solutions are transforming the life sciences industry. Watch this short video to see how our unified platform is accelerating clinical research operations for companies worldwide. 🔍 Key Features: Comprehensive CTMS Efficient eTMF management Seamless EDC integration Robust panelist recruitment Reliable randomization processes Join us on our journey to innovate and streamline clinical trials, making research faster and more efficient than ever before. 📺 Watch now and learn more about how Cloudbyz is leading the way in clinical research technology! #Cloudbyz #eClinicalSolutions #ClinicalTrials #LifeSciences #Innovation #Technology

18

1 Comment

Discover how our cutting-edge eClinical solutions are transforming the life sciences industry. Watch this short video to see how our unified platform is accelerating clinical research operations for companies worldwide. 🔍 Key Features: Comprehensive CTMS Efficient eTMF management Seamless EDC integration Robust panelist recruitment Reliable randomization processes Join us on our journey to innovate and streamline clinical trials, making research faster and more efficient than ever before. 📺 Watch now and learn more about how Cloudbyz is leading the way in clinical research technology! #Cloudbyz #eClinicalSolutions #ClinicalTrials #LifeSciences #Innovation #Technology

3

Discover how our cutting-edge eClinical solutions are transforming the life sciences industry. Watch this short video to see how our unified platform is accelerating clinical research operations for companies worldwide. 🔍 Key Features: Comprehensive CTMS Efficient eTMF management Seamless EDC integration Robust panelist recruitment Reliable randomization processes Join us on our journey to innovate and streamline clinical trials, making research faster and more efficient than ever before. 📺 Watch now and learn more about how Cloudbyz is leading the way in clinical research technology! #Cloudbyz #eClinicalSolutions #ClinicalTrials #LifeSciences #Innovation #Technology

3

Discover how our cutting-edge eClinical solutions are transforming the life sciences industry. Watch this short video to see how our unified platform is accelerating clinical research operations for companies worldwide. 🔍 Key Features: Comprehensive CTMS Efficient eTMF management Seamless EDC integration Robust panelist recruitment Reliable randomization processes Join us on our journey to innovate and streamline clinical trials, making research faster and more efficient than ever before. 📺 Watch now and learn more about how Cloudbyz is leading the way in clinical research technology! #Cloudbyz #eClinicalSolutions #ClinicalTrials #LifeSciences #Innovation #Technology

6

30% Faster AE Reporting with Cloudbyz! In a recent surgical valve trial, the sponsor reduced the time spent on submitting expedited AE reports by 30% using the Cloudbyz Safety Database. Simplifying safety reporting every step of the way. We’re at the World Drug Safety Congress Europe this week! Meet our team to learn how Cloudbyz can help streamline your safety processes. Meet the team in Amsterdam: https://hubs.li/Q02S9d4y0 Not attending? You can still book a demo here: https://hubs.li/Q02S9fZm0 #Cloudbyz #Pharmacovigilance #AEReporting #Compliance #SafetyDatabase #LifeSciences #MeetUs #WorldDrugSafety

10